Related Experiment Videos
Transfusion-associated chronic cutaneous graft-versus-host disease
R J Hull1, R A Bray, C Hillyer
1Department of Medicine, Emory University School of Medicine, GA 30322, USA.
Journal of the American Academy of Dermatology
|August 1, 1995
Summary
Transfusion-associated graft-versus-host disease (TAGVHD) is a rare, often fatal complication in immunocompromised patients. This case highlights TAGVHD evolving into chronic disease despite white blood cell filters, suggesting current prevention methods are inadequate.
Area of Science:
- Hematology
- Immunology
- Transfusion Medicine
Background:
- Transfusion-associated graft-versus-host disease (TAGVHD) is a severe complication in immunocompromised individuals receiving non-irradiated blood products.
- TAGVHD typically presents as an acute illness with a high mortality rate.
Observation:
- A patient with non-Hodgkin's lymphoma developed acute TAGVHD after receiving packed red blood cells from two unrelated donors.
- The patient survived the acute phase and later exhibited chronic cutaneous graft-versus-host disease.
- HLA phenotyping indicated engraftment from both transfusion donors.
Findings:
- TAGVHD can occur despite white blood cell filtration of blood products.
- The disorder, though rare and potentially underdiagnosed, may transition from acute to chronic forms.
- Current filtration methods may not be sufficient to prevent TAGVHD.
Implications:
- This case underscores the need for improved strategies to prevent TAGVHD in at-risk populations.
- Awareness of TAGVHD's potential evolution into chronic forms is crucial for patient management.
- Further research into effective preventative measures for TAGVHD is warranted.